Umstead John V. 4
4 · G1 Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Umstead John V.
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-15+50,000→ 58,886 total - Award
Stock Options (Right to Buy)
2023-03-15+100,000→ 100,000 totalExercise: $3.27Exp: 2033-03-15→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests 25% on March 15, 2024 and 25% annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 2,036 shares of common stock; (ii) 850 RSUs from award granted on January 4, 2021; (iii) 3,000 RSUs from award granted on January 3, 2022; (iv) 3,000 RSUs from award granted on January 3, 2023; and (v) 50,000 RSUs from award granted on March 15, 2023.
- [F4]The shares underlying this option vest as to 25% of the shares on March 15, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.